Development Level

Tbio 2 | 10,625
Tchem 2 | 1,890

Disease

Arthritis 4 | 248
Cancer 4 | 2,346
psoriasis 4 | 6,685
Complex regional pain syndrome 3 | 12
Migraine 3 | 79
Pain agnosia 3 | 99
Allergic hypersensitivity disease 2 | 123
Alzheimer's disease 2 | 644
Anxiety disorder 2 | 22
Arthritis, Experimental 2 | 39
Asthma 2 | 349
Autistic Disorder 2 | 320
Bronchial Hyperreactivity 2 | 13
Common Migraine 2 | 11
Dermatitis 2 | 107
Diarrhea 2 | 155
Down syndrome 2 | 548
Edema 2 | 38
Epicondylitis 2 | 19
Fibromyalgia 2 | 22
Huntington's disease 2 | 72
Hyperactive behavior 2 | 31
Hyperalgesia 2 | 71
Hypertension 2 | 287
Inflammation 2 | 109
Inflammatory bowel disease 2 | 142
Irritable bowel syndrome 2 | 59
Major Depressive Disorder 2 | 106
Narcolepsy 2 | 58
Neurogenic Inflammation 2 | 12
Neuropathy 2 | 210
Pancreatitis 2 | 97
Parkinson's disease 2 | 364
Rhinitis 2 | 46
Schizophrenia 2 | 501
Urticaria 2 | 53
adult high grade glioma 2 | 2,148
diabetes mellitus 2 | 1,663
glioblastoma 2 | 5,572
head and neck cancer and chronic obstructive pulmonary disease 2 | 237
interstitial cystitis 2 | 2,299
lung cancer 2 | 4,466
pilocytic astrocytoma 2 | 3,086
pituitary cancer 2 | 1,972
Alcohol dependence 1 | 107
Amnesia 1 | 17
Angioedema 1 | 36
Anxiety Disorders 1 | 37
Autoimmune thyroiditis 1 | 24
Bipolar Disorder 1 | 266
Bradycardia 1 | 24
Bronchitis 1 | 44
Calcinosis 1 | 62
Catalepsy 1 | 15
Colorectal Neoplasms 1 | 217
Constipation 1 | 43
Degenerative polyarthritis 1 | 93
Dementia 1 | 129
Drug Eruptions 1 | 18
Drug allergy 1 | 36
Eating disorder 1 | 24
Extravasation of Diagnostic and Therapeutic Materials 1 | 6
Gas gangrene 1 | 15
Gastroesophageal reflux disease 1 | 37
Globe disease 1 | 57
Goiter 1 | 27
Hepatitis C 1 | 90
Hirschsprung's disease 1 | 42
Hypercalcemia 1 | 37
Hyperparathyroidism 1 | 43
Hypersensitivity 1 | 63
Hyperthyroidism 1 | 50
Hypogonadism 1 | 70
Hypoparathyroidism 1 | 29
Hypophosphatemia 1 | 31
Hypotension 1 | 53
Kidney failure 1 | 39
Migraine Disorders 1 | 26
Motion sickness 1 | 32
Multiple endocrine neoplasia type 2A 1 | 22
Myofascial pain syndrome 1 | 7
Neuralgia 1 | 16
Osteogenesis imperfecta 1 | 34
Osteomalacia 1 | 28
Osteoporosis 1 | 257
Paget's disease of bone 1 | 28
Pain 1 | 70
Pain disorder 1 | 13
Phaeochromocytoma 1 | 20
Pulmonary Fibrosis 1 | 66
Pulmonary hypertension 1 | 52
Rickets 1 | 42
Root resorption 1 | 21
Sudden infant death syndrome 1 | 33
Thyroiditis 1 | 25
Thyrotoxicosis 1 | 38
Toxic encephalopathy 1 | 131
chronic kidney disease 1 | 90
facioscapulohumeral dystrophy 1 | 286
limb girdle muscular dystrophy 2B 1 | 74

Tissue

Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Nervous System 4 | 18,561
Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444

Target Family

Non-IDG 3 | 11,971
Enzyme 1 | 4,146

Grant Application

5R01NS048565-03 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Phospholipase A2, membrane associated PLA2G2A Tchem Enzyme -2.81886 723.7 112
Calcitonin CALCA Tbio Non-IDG -3.94865 8776.7 1056
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Protachykinin-1 TAC1 Tbio Non-IDG -4.12709 13651.7 395